AbbVie (NYSE: ABBV) recently dipped nearly 20% and is still down 14%, offering an enticing 3.7% forward yield. Here's what ...

Humira is used to treat certain inflammatory conditions. It’s mainly covered by Medicare Part D when self-administered or, more rarely, by Part B when administered by a doctor. Humira ...

The availability of Humira biosimilars potentially affects a vast number of patients and healthcare professionals. Our team of clinicians explored all of the different biosimilars set to enter the ...

AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...

As pharmaphorum recently reported, the entrance of biosimilars to Humira is a significant event for a number of reasons, not least because the drug is the top-selling pharmaceutical product of all ...

The North Chicago-based drugmaker said it's received positive topline results in a Phase 3 trial of its investigational ...

AbbVie ABBV over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table ...

The Zacks Daily presents the best research output of our analyst team. Today's Daily features new research reports on 16 ...

Teva Pharmaceutical shares have rebounded from lows, driven by debt reduction. Check out why I rate TEVA stock as Strong Buy.

Biogen (NASDAQ:BIIB – Get Free Report) was downgraded by equities research analysts at Jefferies Financial Group from a “buy” ...

Number bonds are pairs of numbers which add up to a certain number. Learn about the number bonds of 10 and 20 with this video. We’re hunting down some number bonds. Number bonds are a pair of ...

In the Fall of 1963, a Korean War veteran and criminal pleads insanity and is admitted to a mental institution, where he rallies up the scared patients against the tyrannical nurse. A rogue Multiverse ...